DYN

Dyne Therapeutics, Inc.NASDAQHealthcare

$18.84-2.60%ClosedMarket Cap: $3.11B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-09	Chardan Capital	—	Buy	—
2026-03-03	HC Wainwright & Co.	—	Buy	—
2026-03-03	Morgan Stanley	—	Overweight	—
2026-01-20	JP Morgan	—	Neutral	—
2025-12-15	Evercore ISI Group	—	Outperform	—
2025-12-11	Stifel	—	Buy	—
2025-12-10	Oppenheimer	—	Outperform	—
2025-12-09	Morgan Stanley	—	Overweight	—
2025-12-09	Chardan Capital	—	Buy	—
2025-12-08	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.09	$65.1M	10
Sun Dec 31	$-2.27	$300.5M	9
Mon Dec 31	$-0.27	$852.2M	3
Tue Dec 31	$2.17	$1.41B	3